Skip to main content
OpenTrials

Clinical trial condition

Meningococcal Infections

Explore clinical trials studying Meningococcal Infections. Study availability and eligibility vary by location and protocol.

216 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Meningococcal Infections trial results

Completed

Safety and Immunogenicity of GlaxoSmithKline Biologicals Meningococcal Group B Vaccine When Administered Concomitantly With GlaxoSmithKline Biologicals MenACWY Conjugate Vaccine to Healthy Infants

NCT02106390

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Diseases, +8 more
Locations
  • GSK Investigational Site Buenos Aires, Argentina
  • GSK Investigational Site Buenos Aires, Argentina
  • GSK Investigational Site Córdoba, Argentina
  • GSK Investigational Site Mexico City, Mexico
View Trial Details
Completed

Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine GSK 134612 Versus Menactra® in Healthy Adolescents/Adults

NCT01165242

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • GSK Investigational Site Chandler, Arizona, United States
  • GSK Investigational Site Paramount, California, United States
  • GSK Investigational Site Sacramento, California, United States
  • GSK Investigational Site Sacramento, California, United States
View all 32 locations
View Trial Details
Completed

Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine or Meningococcal C Conjugate Vaccine

NCT01345721

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
Locations
  • Dr. Johannes Kandzora and Dr. Kathrin Kandzora Am Teich 11, Neumuenster, Germany
  • Bogda-Maria Kniese, Boyneburgstr 7, Eschwege, Germany
  • Dr Goertz Martin Kimmig GroBbottwarer Str 47, Oberstenfeld, Germany
  • Dr med Walter Otto Heinrichstrasse 16 A, Fulda, Germany
View Trial Details
Completed

Assessment of Antibody Persistence at Eighteen Months After the Completion of the Vaccination Course in Study V72P10

NCT01148524

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +13 more
Locations
  • Centro de Salud Lo Barnechea Santiago, Chile
  • Centro para vacunas en desarrollo. Hospital de Niños Roberto del Río Santiago, Chile
  • Escuela de Medicina de la Universidad de Valparaíso Santiago, Chile
  • Hospital Luis Calvo Mackenna Santiago, Chile
View Trial Details
Completed

Immunogenicity and Safety of Meningococcal Vaccine GSK134612 vs. Menactra® in Healthy Adolescent/Adults Aged 10-25 Years.

NCT00454909

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • GSK Investigational Site Daly City, California, United States
  • GSK Investigational Site Fairfield, California, United States
  • GSK Investigational Site Redwood City, California, United States
  • GSK Investigational Site Sacramento, California, United States
View Trial Details
Completed

Primary Study to Demonstrate Non-inferiority and Immunogenicity of GSK Biologicals' Meningococcal Vaccine 134612

NCT00465816

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • GSK Investigational Site Aarhus N, Denmark
  • GSK Investigational Site Karlskrona, Sweden
  • GSK Investigational Site Linköping, Sweden
  • GSK Investigational Site Malmö, Sweden
View Trial Details

Related conditions